Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GLUTAMATE ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 163 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Robinson, S; Krentz, L; Moore, C; Meshul, CK
      Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats

      SYNAPSE
    2. Clarke, CE; Cooper, JA; Holdich, TAH
      A randomized, double-blind, placebo-controlled, ascending-dose tolerability and safety study of remacemide as adjuvant therapy in Parkinson's diseasewith response fluctuations

      CLINICAL NEUROPHARMACOLOGY
    3. Darracq, L; Drouin, C; Blanc, G; Glowinski, J; Tassin, JP
      Stimulation of metabotropic but not ionotropic glutamatergic receptors in the nucleus accumbens is required for the D-amphetamine-induced release of functional dopamine

      NEUROSCIENCE
    4. Lee, JY; Kim, YH; Koh, YJ
      Protection by pyruvate against transient forebrain ischemia in rats

      JOURNAL OF NEUROSCIENCE
    5. Shoulson, I; Penney, J; McDermott, M; Kieburtz, K; Schwid, SR; Kayson, E; Chase, T; Fahn, S; Greenamyre, JT; Lang, A; Siderowf, A; Pearson, N; Harrison, M; Rost-Ruffner, E; Colcher, A; Lloyd, M; Matthews, M; Pahwa, R; McGuire, D; Lew, MF; Schuman, S; Marek, K; Broshjeit, S; Factor, S; Brown, D; Feigin, A; Mazurkiewicz, J; Ford, B; Jennings, D; Dillon, S; Comella, C; Blasucci, L; Janko, K; Shulman, L; Wiener, W; Bateman-Rodriguez, D; Carrion, A; Suchowersky, O; Lafontaine, AL; Pantella, C; Siemers, E; Belden, J; Davies, R; Lannon, M; Grimes, D; Gray, P; Martin, W; Kennedy, L; Adler, C; Newman, S; Hammerstad, J; Stone, C; Lewitt, P; Bardram, K; Mistura, K; Miyasaki, J; Johnston, L; Cha, JHJ; Tennis, M; Panisset, M; Hall, J; Tetrud, J; Friedlander, J; Hauser, R; Gauger, L; Rodnitzky, R; Deleo, A; Dobson, J; Seeberger, L; Dingmann, C; Tarsy, D; Ryan, P; Elmer, L; Ruzicka, D; Stacy, M; Brewer, M; Locke, B; Baker, D; Casaceli, C; Day, D; Florack, M; Hodgeman, K; Laroia, N; Nobel, R; Orme, C; Rexo, L; Rothenburgh, K; Sulimowicz, K; Watts, A; Wratni, E; Tariot, P; Cox, C; Leventhal, C; Alderfer, V; Craun, AM; Frey, J; McCree, L; McDermott, J; Cooper, J; Holdich, T; Read, B
      A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease

      NEUROLOGY
    6. Reggiani, A; Pietra, C; Arban, R; Marzola, P; Guerrini, U; Ziviani, L; Boicelli, A; Sbarbati, A; Osculati, F
      The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Rao, VLR; Dogan, A; Todd, KG; Bowen, KK; Dempsey, RJ
      Neuroprotection by memantine, a non-competitive antagonist after traumaticbrain injury NMDA receptor in rats

      BRAIN RESEARCH
    8. Classey, JD; Knight, YE; Goadsby, PJ
      The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat

      BRAIN RESEARCH
    9. Vilagi, I; Klapka, N; Luhmann, HJ
      Optical recording of spreading depression in rat neocortical slices

      BRAIN RESEARCH
    10. Lees, GJ; Leong, W
      In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466

      BRAIN RESEARCH
    11. Shoulson, I; Lang, A; Fahn, S; McDermott, M; Kieburtz, K; Schwid, S; Kayson, E; Chase, T; Greenamyre, T; Penney, J; Frucht, S; Winfield, H; Goetz, C; Blasucci, L; Nutt, J; Carter, J; Morehouse, S; Rajput, A; Ewanishin, M; Johnston, L; Casaceli, C; Day, D; Hodgeman, K; Laroia, N; de Marcaida, JA; Orme, C; Watts, A; Natarajan, R; Huang, P; Tariot, P; Cox, C; Leventhal, C
      Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trialof remacemide in advanced Parkinson disease

      ARCHIVES OF NEUROLOGY
    12. Schachter, SC; Tarsy, D
      Remacemide: current status and clinical applications

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    13. Kawai, N; Nakamura, T; Okauchi, M; Nagao, S
      Effects of hypothermia on intracranial pressure and brain edema formation:Studies in a rat acute subdural hematoma model

      JOURNAL OF NEUROTRAUMA
    14. Luginger, E; Wenning, GK; Bosch, S; Poewe, W
      Beneficial effects of amantadine on L-Dopa-induced dyskinesias in Parkinson's disease

      MOVEMENT DISORDERS
    15. Halmos, G; Gaborjan, A; Lendvai, B; Repassy, G; Szabo, LZ; Vizi, ES
      Veratridine-evoked release of dopamine from guinea pig isolated cochlea

      HEARING RESEARCH
    16. Lapchak, PA; Araujo, DM; Shackelford, DA; Zivin, JA
      Prosaptide exacerbates ischemia-induced behavioral deficits in vivo; An effect that does not involve mitogen-activated protein kinase activation

      NEUROSCIENCE
    17. Ruzicka, E; Streitova, H; Jech, R; Kanovsky, P; Roth, J; Rektorova, I; Mecir, P; Hortova, H; Bares, M; Hejdukova, B; Rektor, I
      Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    18. Yam, PS; Dunn, LT; Graham, DI; Dewar, D; McCulloch, J
      NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    19. Shisler, RJ; Baylis, GC; Frank, EM
      Pharmacological approaches to the treatment and prevention of aphasia

      APHASIOLOGY
    20. Callaway, JK; Knight, MJ; Watkins, DJ; Beart, PM; Jarrott, B; Delaney, PM
      A novel, rapid, computerised method for quantitation of neuronal damage ina rat model of stroke

      JOURNAL OF NEUROSCIENCE METHODS
    21. Chhabra, SR; Khan, AN; Bycroft, BW
      Solid-phase synthesis of polyamines using a Dde-linker: philanthotoxin-4.3.3 via an on-resin Mitsunobu reaction

      TETRAHEDRON LETTERS
    22. Clark, WM; Raps, EC; Tong, DC; Kelly, RE
      Cervene (nalmefene) in acute ischemic stroke - Final results of a phase III efficacy study

      STROKE
    23. Shoulson, I; Greenamyre, T; Kieburtz, K; Schwid, S; McDermott, M; Kayson, E; Chase, T; Fahn, S; Lang, A; Penney, J; Hauser, R; Gauger, L; Kumar, R; Keable, L; Sime, E; Siemers, E; Belden, J; Pappert, EJ; Janko, K; Trugman, JM; Rost-Ruffner, E; Kurlan, R; Pearson, N; Carter, J; Nutt, J; Stone, C; Perlmutter, JS; McGee-Minnich, L; Freeman, A; Duddleston, C; Stacy, M; Brewer, M; Locke, B; Stern, M; Matthews, M; Friedman, J; Davies, R; Lannon, M; Grimes, D; Gray, P; Shults, C; Fontaine, D; O'Brien, C; Dingmann, C; Feigin, A; Mazurkiewicz, J; Elmer, L; Wernette, K; Singer, C; Bateman-Rodriguez, D; Carrion, A; Fernandez, M; Pfeiffer, R; Pfeiffer, B; Rast, S; Pahwa, R; McGuire, D; Brin, M; Walker, R; Casaceli, C; Day, D; Hodgeman, K; Huang, P; Orme, C; Sulimowicz, K; Watts, A; Means, E; Alderfer, V; Letizia, J; Craun, AM; Cooper, J; Holdich, T; Read, B
      A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD

      NEUROLOGY
    24. Hakuba, N; Koga, K; Shudou, M; Watanabe, F; Mitani, A; Gyo, K
      Hearing loss and glutamate efflux in the perilymph following transient hindbrain ischemia in gerbils

      JOURNAL OF COMPARATIVE NEUROLOGY
    25. Wonnacott, S; Kaiser, S; Mogg, A; Soliakov, L; Jones, IW
      Presynaptic nicotinic receptors modulating dopamine release in the rat striatum

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Bokesch, PM; Kapural, M; Drummond-Webb, J; Baird, K; Kapural, L; Mee, RBB; Trapp, B; Starr, NJ
      Neuroprotective, anesthetic, and cardiovascular effects of the NMDA antagonist, CNS 5161A, in isoflurane-anesthetized lambs

      ANESTHESIOLOGY
    27. Taylor-Robinson, SD; Turjanski, N; Bhattacharya, S; Seery, JP; Sargentoni, J; Brooks, DJ; Bryant, DJ; Cox, IJ
      A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease

      METABOLIC BRAIN DISEASE
    28. Merello, M; Nouzeilles, MI; Cammarota, A; Leiguarda, R
      Effect of memantine (NMDA antagonist) on Parkinson's disease: A double-blind crossover randomized study

      CLINICAL NEUROPHARMACOLOGY
    29. Schwid, SR; Kieburtz, K; Nutt, J; McDermott, M; Kayson, E; Chase, T; Fahn, S; Greenamyre, T; Lang, A; Penney, J; Shoulson, I
      The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    30. Sgambato, V; Maurice, N; Besson, MJ; Thierry, AM; Deniau, JM
      Effect of a functional impairment of corticostriatal transmission on cortically evoked expression of c-fos and zif 268 in the rat basal ganglia

      NEUROSCIENCE
    31. Christensen, T; Balchen, T; Bruhn, T; Diemer, NH
      Double-tracer autoradiographic study of protein synthesis and glucose consumption in rats with focal cerebral ischemia

      NEUROLOGICAL RESEARCH
    32. Teasdale, GM; Maas, A; Iannotti, F; Ohman, J; Unterberg, A
      Challenges in translating the efficacy of neuroprotective agents in experimental models into knowledge of clinical benefits in head injured patients

      CURRENT PROGRESS IN THE UNDERSTANDING OF SECONDARY BRAIN DAMAGE FROM TRAUMA AND ISCHEMIA
    33. Schielke, GP; Kupina, NC; Boxer, PA; Bigge, CF; Welty, DF
      The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat

      STROKE
    34. Salt, TE; Turner, JP; Kingston, AE
      Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo

      NEUROPHARMACOLOGY
    35. Blandini, F; Greenamyre, JT
      Protective and symptomatic strategies for therapy of Parkinson's disease

      DRUGS OF TODAY
    36. Blanchet, PJ; Konitsiotis, S; Whittemore, ER; Zhou, ZL; Woodward, RM; Chase, TN
      Differing effects of N-methl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    37. Morris, GF; Bullock, R; Marshall, SB; Marmarou, A; Maas, A; Marshall, LF
      Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trials

      JOURNAL OF NEUROSURGERY
    38. Jolkkonen, J; Puurunen, K; Koistinaho, J; Kauppinen, R; Haapalinna, A; Nieminen, L; Sivenius, J
      Neuroprotection by the alpha(2)-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia

      EUROPEAN JOURNAL OF PHARMACOLOGY
    39. Oh, JD; Vaughan, CL; Chase, TN
      Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

      BRAIN RESEARCH
    40. Orendacova, J
      Structural changes induced in rat spinal cord by MK-801: light and electron microscopical observations

      BIOLOGIA
    41. Gorgulu, A; Kiris, T; Unal, F; Turkoglu, U; Kucuk, M; Cobanoglu, S
      Protective effect of the N-methyl-D-aspartate receptor antagonists, MK-801and CPP on cold-induced brain oedema

      ACTA NEUROCHIRURGICA
    42. Ishizaki, K; Sasaki, M; Karasawa, S; Obata, H; Nara, T; Goto, F
      Intrathecal co-administration of NMDA antagonist and NK-1 antagonist reduces MAC of isoflurane in rats

      ACTA ANAESTHESIOLOGICA SCANDINAVICA
    43. BARKSDALE CM; NORDBLOM GD; DUDECK RC; WELTY DF; JORDAN S; BIGGE CF; YI CS
      DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR PD 152247 (PNQX)EQUIVALENT CONCENTRATIONS IN RAT-BRAIN MICRODIALYSATE FLUID

      Journal of clinical ligand assay
    44. ORNSTEIN PL; ARNOLD MB; LUNN WHW; HEINZ LJ; LEANDER JD; LODGE D; SCHOEPP DD
      HETEROATOM-SUBSTITUTION AS A STRATEGY FOR INCREASING THE POTENCY OF COMPETITIVE NMDA ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    45. BEIRNE JP; PEARLSTEIN RD; MASSEY GW; WARNER DS
      EFFECT OF HALOTHANE IN CORTICAL CELL-CULTURES EXPOSED TO N-METHYL-D-ASPARTATE

      Neurochemical research
    46. ZHANG C; RAGHUPATHI R; SAATMAN KE; SMITH DH; STUTZMANN JM; WAHL F; MCINTOSH TK
      RILUZOLE ATTENUATES CORTICAL LESION SIZE, BUT NOT HIPPOCAMPAL NEURONAL LOSS, FOLLOWING TRAUMATIC BRAIN INJURY IN THE RAT

      Journal of neuroscience research
    47. SALT TE; TURNER JP
      REDUCTION OF SENSORY AND METABOTROPIC GLUTAMATE-RECEPTOR RESPONSES INTHE THALAMUS BY THE NOVEL METABOTROPIC GLUTAMATE RECEPTOR-1-SELECTIVEANTAGONIST S-2-METHYL-4-CARBOXY-PHENYLGLYCINE

      Neuroscience
    48. Back, T
      Pathophysiology of the ischemic penumbra - Revision of a concept

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    49. LANG AE; LOZANO AM
      PARKINSONS-DISEASE - 2ND OF 2 PARTS

      The New England journal of medicine
    50. KINGSTON AE; ORNSTEIN PL; WRIGHT RA; JOHNSON BG; MAYNE NG; BURNETT JP; BELAGAJE R; WU S; SCHOEPP DD
      LY341495 IS A NANOMOLAR POTENT AND SELECTIVE ANTAGONIST OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS

      Neuropharmacology
    51. CHASE TN; OH JD; BLANCHET PJ
      NEOSTRIATAL MECHANISMS IN PARKINSONS-DISEASE

      Neurology
    52. TAKAHASHI M; NI JW; KAWASAKIYATSUGI S; TOYA T; YATSUGI SI; SHIMIZUSASAMATA M; KOSHIYA K; SHISHIKURA JI; SAKAMOTO S; YAMAGUCHI T
      YM872, A NOVEL SELECTIVE LPHA-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR ANTAGONIST, REDUCES BRAIN-DAMAGE AFTER PERMANENT FOCAL CEREBRAL-ISCHEMIA IN CATS

      The Journal of pharmacology and experimental therapeutics
    53. BULLOCK R; ZAUNER A; WOODWARD JJ; MYSEROS J; CHOI SC; WARD JD; MARMAROU A; YOUNG HF
      FACTORS AFFECTING EXCITATORY AMINO-ACID RELEASE FOLLOWING SEVERE HUMAN HEAD-INJURY

      Journal of neurosurgery
    54. HERZ RCG; KASBERGEN CM; VERSTEEG DHG; DEWILDT DJ
      THE EFFECT OF THE ADRENOCORTICOTROPIN-(4-9) ANALOG, ORG-2766, AND OF DIZOLCIPINE (MK-801) ON INFARCT VOLUME IN RAT-BRAIN

      European journal of pharmacology
    55. DAVIDSON EM; CARLTON SM
      INTRAPLANTAR INJECTION OF DEXTRORPHAN, KETAMINE OR MEMANTINE ATTENUATES FORMALIN-INDUCED BEHAVIORS

      Brain research
    56. Oh, JD; Russell, D; Vaughan, CL; Chase, TN
      Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration

      BRAIN RESEARCH
    57. SAJI H; KINOSHITA T; KUBOTA M; KANEDA K; AKAIKE A; KIKUCHI M; KASHII S; HONDA Y; IIDA Y; MAGATA Y; YOKOYAMA A
      BRAIN PERMEABLE ZINC COMPLEX WITH NEUROPROTECTIVE ACTION

      STP pharma sciences
    58. WAHLGREN NG
      NEUROPROTECTANTS IN LATE CLINICAL DEVELOPMENT - A STATUS-REPORT

      Cerebrovascular diseases
    59. TSUCHIDA E; RICE M; BULLOCK R
      THE NEUROPROTECTIVE EFFECT OF THE FOREBRAIN-SELECTIVE NMDA ANTAGONISTCP101,606 UPON FOCAL ISCHEMIC BRAIN-DAMAGE CAUSED BY ACUTE SUBDURAL-HEMATOMA IN THE RAT

      Journal of neurotrauma
    60. CARLTON SM; REES H; GONDESEN K; WILLIS WD
      DEXTRORPHAN ATTENUATES RESPONSES OF SPINOTHALAMIC TRACT CELLS IN NORMAL AND NERVE-INJURED MONKEYS

      Neuroscience letters
    61. MIES G
      BLOOD-FLOW DEPENDENT DURATION OF CORTICAL DEPOLARIZATIONS IN THE PERIPHERY OF FOCAL ISCHEMIA OF RAT-BRAIN

      Neuroscience letters
    62. DAVIS SM; ALBERS GW; DIENER HC; LEES KR; NORRIS J
      TERMINATION OF ACUTE STROKE STUDIES INVOLVING SELFOTEL TREATMENT

      Lancet
    63. MIYABE M; KIRSCH JR; NISHIKAWA T; KOEHLER RC; TRAYSTMAN RJ
      COMPARATIVE-ANALYSIS OF BRAIN PROTECTION BY N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS AFTER TRANSIENT FOCAL ISCHEMIA IN CATS

      Critical care medicine
    64. TAKANO K; TATLISUMAK T; FORMATO JE; CARANO RAD; BERGMANN AG; PULLAN LM; BARE TM; SOTAK CH; FISHER M
      GLYCINE SITE ANTAGONIST ATTENUATES INFARCT SIZE IN EXPERIMENTAL FOCALISCHEMIA - POSTMORTEM AND DIFFUSION MAPPING STUDIES

      Stroke
    65. ONAL MZ; LI FH; TATLISUMAK T; LOCKE KW; SANDAGE BW; FISHER M
      SYNERGISTIC EFFECTS OF CITICOLINE AND MK-801 IN TEMPORARY EXPERIMENTAL FOCAL ISCHEMIA IN RATS

      Stroke
    66. DI X; BULLOCK R; WATSON J; FATOUROS P; CHENARD B; WHITE F; CORWIN F
      EFFECT OF CP101,606, A NOVEL NR2B SUBUNIT ANTAGONIST OF THE N-METHYL-D-ASPARTATE RECEPTOR, ON THE VOLUME OF ISCHEMIC BRAIN-DAMAGE AND CYTOTOXIC BRAIN EDEMA AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION IN THE FELINE BRAIN

      Stroke
    67. DAUBAN P; DODD RH
      2,3-AZIRIDINO-2,3-DIDEOXY-D-RIBONO-GAMMA-LACTONE 5-PHOSPHONATE - STEREOCONTROLLED SYNTHESIS FROM D-LYXOSE AND UNUSUAL AZIRIDINE RING-OPENING

      Journal of organic chemistry
    68. ROBERTSON SC; WETJEN NM; BEER BJ; LOFTUS CM
      PREISCHEMIC AND POSTISCHEMIC EFFECTS OF THE NMDA RECEPTOR ANTAGONIST DIZOCILPINE MALEATE (MK-801) ON COLLATERAL CEREBRAL BLOOD-FLOW

      Journal of neurosurgery
    69. OKADA M; UEDA H; KOMETANI M; NAKAO K
      EFFECT OF D-(E)-2-AMINO-4-METHYL-5-PHOSPHONO-3-PENTENOIC ACID ON FOCAL CEREBRAL-ISCHEMIA IN CAT

      Arzneimittel-Forschung
    70. FURUYA N; KOIZIMI T; SEBATA H
      EFFECTS OF NEWLY DEVELOPED EXCITATORY AMINO-ACID ANTAGONISTS ON VESTIBULAR TYPE-I NEURONS IN THE CAT

      Acta oto-laryngologica
    71. GREDAL O; WERDELIN L; BAK S; CHRISTENSEN PB; BOYSEN G; KRISTENSEN MO; JESPERSEN JH; REGEUR L; HINGE HH; JENSEN TS
      A CLINICAL-TRIAL OF DEXTROMETHORPHAN IN AMYOTROPHIC-LATERAL-SCLEROSIS

      Acta neurologica Scandinavica
    72. AUER RN; COUPLAND SG; JASON GW; ARCHER DP; PAYNE J; BELZBERG AJ; OHTAKI M; TRANMER BI
      POSTISCHEMIC THERAPY WITH MK-801 (DIZOCILPINE) IN A PRIMATE MODEL OF TRANSIENT FOCAL BRAIN ISCHEMIA

      Molecular and chemical neuropathology
    73. HOSSMANN KA
      PERIINFARCT DEPOLARIZATIONS

      Cerebrovascular and brain metabolism reviews
    74. DI X; HARPOLD T; WATSON JC; BULLOCK MR
      EXCITOTOXIC DAMAGE IN NEUROTRAUMA - FACT OR FICTION

      Restorative neurology and neuroscience
    75. OGATA T; NAKAMURA Y; TSUJI K; OKUMURA H; KATAOKA K; SHIBATA T
      ROLE OF ASPARTATE IN ISCHEMIC SPINAL-CORD DAMAGE

      Journal of orthopaedic research
    76. BIROS MH; NORDNESS R
      EFFECTS OF CHEMICAL PRETREATMENT ON POSTTRAUMATIC CORTICAL EDEMA IN THE RAT

      The American journal of emergency medicine
    77. HUANG DW; MATILE S; BEROVA N; NAKANISHI K
      SYNTHESIS OF PHILANTHOTOXIN ANALOGS WITH BULKY HEADS INCLUDING PORPHYRINS - SELF-ASSEMBLY MONITORED BY CIRCULAR-DICHROISM

      Heterocycles
    78. SILVER B; WEBER J; FISHER M
      MEDICAL THERAPY FOR ISCHEMIC STROKE

      Clinical neuropharmacology
    79. YATSUGI S; TAKAHASHI M; KAWASAKIYATSUGI S; KOSHIYA K; SAKAMOTO S; UEMATSU D; SHIMIZUSASAMATA M
      NEUROPROTECTIVE EFFECT OF YM90K, A NOVEL AMPA KAINATE RECEPTOR ANTAGONIST, IN FOCAL CEREBRAL-ISCHEMIA IN CATS/

      Journal of cerebral blood flow and metabolism
    80. BOWES MP; SWANSON S; ZIVIN JA
      THE AMPA ANTAGONIST LY293558 IMPROVES FUNCTIONAL NEUROLOGICAL OUTCOMEFOLLOWING REVERSIBLE SPINAL-CORD ISCHEMIA IN RABBITS

      Journal of cerebral blood flow and metabolism
    81. MCCULLOCH J
      NEUROPROTECTIVE DRUG DEVELOPMENT IN STROKE - BLOOD-PRESSURE AND ITS IMPACT

      Journal of hypertension
    82. DORMAN PJ; SANDERCOCK PAG
      CONSIDERATIONS IN THE DESIGN OF CLINICAL-TRIALS OF NEUROPROTECTIVE THERAPY IN ACUTE STROKE

      Stroke
    83. JAROSZEWSKI JW; MATZEN L; FROLUND B; KROGSGAARDLARSEN P
      NEUROACTIVE POLYAMINE WASP TOXINS - NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPIC ANALYSIS OF THE PROTOLYTIC PROPERTIES OF PHILANTHOTOXIN-343

      Journal of medicinal chemistry
    84. ORNSTEIN PL; ARNOLD MB; ALLEN NK; BLEISCH T; BORROMEO PS; LUGAR CW; LEANDER JD; LODGE D; SCHOEPP DD
      STRUCTURE-ACTIVITY STUDIES OF 6-(TETRAZOLYLALKYL)-SUBSTITUTED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AMPA RECEPTOR ANTAGONISTS .1. EFFECTSOF STEREOCHEMISTRY, CHAIN-LENGTH, AND CHAIN SUBSTITUTION

      Journal of medicinal chemistry
    85. MANFRIDI A; MANCIA M
      DESYNCHRONIZED (REM) SLEEP INHIBITION INDUCED BY CARBACHOL MICROINJECTIONS INTO THE NUCLEUS BASALIS OF MEYNERT IS MEDIATED BY THE GLUTAMATERGIC SYSTEM

      Experimental Brain Research
    86. BIGGS CS; FOWLER LJ; WHITTON PS; STARR MS
      NMDA RECEPTOR ANTAGONISTS INCREASE THE RELEASE OF DOPAMINE IN THE SUBSTANTIA-NIGRA OF RESERPINE-TREATED RATS

      European journal of pharmacology
    87. TOMS NJ; JANE DE; KEMP MC; BEDINGFIELD JS; ROBERTS PJ
      THE EFFECTS OF (RS)-ALPHA-CYCLOPROPYL-4-PHOSPHONOPHENYLGLYCINE ((RS)-CPPG), A POTENT AND SELECTIVE METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONIST

      British Journal of Pharmacology
    88. WIDDOWSON PS; GYTE AJ; UPTON R; WYATT I
      FAILURE OF GLYCINE SITE NMDA RECEPTOR ANTAGONISTS TO PROTECT AGAINST L-2-CHLOROPROPIONIC ACID-INDUCED NEUROTOXICITY HIGHLIGHTS THE UNIQUENESS OF CEREBELLAR NMDA RECEPTORS

      Brain research
    89. BONDY SC; GUO SX
      EFFECT OF AN NMDA RECEPTOR ANTAGONIST AND A GANGLIOSIDE GM(1) DERIVATIVE UPON ETHANOL-INDUCED MODIFICATION OF PARAMETERS OF OXIDATIVE STRESS IN SEVERAL BRAIN-REGIONS

      Brain research
    90. HERZ RCG; GAILLARD PJ; DEWILDT DJ; VERSTEEG DHG
      DIFFERENCES IN STRIATAL EXTRACELLULAR AMINO-ACID-CONCENTRATIONS BETWEEN WISTAR AND FISCHER-344 RATS AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION

      Brain research
    91. LEES GJ; LEONG W
      RESEARCH REPORT BETWEEN EXCITOTOXINS AND THE NA+ K+-ATPASE INHIBITOR OUABAIN IN CAUSING NEURONAL LESIONS IN THE RAT HIPPOCAMPUS/

      Brain research
    92. CHRISTENSEN T; BRUHN T; FRANK L; DIEMER NH
      DIFFERENTIAL EFFECT OF NMDA AND AMPA RECEPTOR BLOCKADE ON PROTEIN-SYNTHESIS IN THE RAT INFARCT BORDERZONE

      Acta neurologica Scandinavica
    93. DERIU PL; DEMONTIS MP; ANANIA V; CARIA MA; MAMELI O; BECCIU A; TOLU E
      BRAIN ELECTROBIOGENESIS PROTECTION INDUCED BY NIMODIPINE AND MK-801 DURING ACUTE-HYPOXIA IN HYPERTENSIVE RATS

      Pharmacological research
    94. OBERENOVITCH TP
      THE ISCHEMIC PENUMBRA - 20 YEARS ON

      Cerebrovascular and brain metabolism reviews
    95. STARR MS; STARR BS
      LOCOMOTOR EFFECTS OF AMANTADINE IN THE MOUSE ARE NOT THOSE OF A TYPICAL GLUTAMATE ANTAGONIST

      Journal of neural transmission. Parkinson's disease and dementia section
    96. GELB AW; ZHANG C; HAMILTON JT
      IN-VITRO CEREBRAL VASOACTIVE EFFECTS OF MK-801

      Journal of neurosurgical anesthesiology
    97. LYDEN P; LONZO L; NUNEZ S
      COMBINATION CHEMOTHERAPY EXTENDS THE THERAPEUTIC WINDOW TO 60 MINUTESAFTER STROKE

      Journal of neurotrauma
    98. MIES G
      IMAGING TECHNIQUES IN EXPERIMENTAL NEUROL OGY

      Nervenheilkunde
    99. OGATA T; NAKAMURA Y; TSUJI K; SHIBATA T; KATAOKA K
      A POSSIBLE MECHANISM FOR THE HYPOXIA-HYPOGLYCEMIA-INDUCED RELEASE OF EXCITATORY AMINO-ACIDS FROM CULTURED HIPPOCAMPAL ASTROCYTES

      Neurochemical research
    100. STEINBERG GK; YOON EJ; KUNIS DM; SUN GH; MAIER CM; GRANT GA
      NEUROPROTECTION BY N-METHYL-D-ASPARTATE ANTAGONISTS IN FOCAL CEREBRAL-ISCHEMIA IS DEPENDENT ON CONTINUED MAINTENANCE DOSING

      Neuroscience


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 12:41:42